BioCentury | Aug 22, 2011
Company News

Devicor Medical Products Inc., Neoprobe deal

...$21 million during any fiscal year for up to five years (see BioCentury, Aug. 8). Devicor Medical Products Inc....
BioCentury | Aug 8, 2011
Company News

Devicor Medical Products, Neoprobe deal

...begin clinical testing with RIGScan CR, a radiolabeled mAb against TAG-72 cancer antigen, in 2012. Devicor Medical Products Inc....
BioCentury | Apr 5, 2010
Company News

Devicor Medical Products Inc., J&J deal

...markets the Mammotome breast biopsy system. The acceptance period for the offer ends June 15. Devicor Medical Products Inc....
Items per page:
1 - 3 of 3
BioCentury | Aug 22, 2011
Company News

Devicor Medical Products Inc., Neoprobe deal

...$21 million during any fiscal year for up to five years (see BioCentury, Aug. 8). Devicor Medical Products Inc....
BioCentury | Aug 8, 2011
Company News

Devicor Medical Products, Neoprobe deal

...begin clinical testing with RIGScan CR, a radiolabeled mAb against TAG-72 cancer antigen, in 2012. Devicor Medical Products Inc....
BioCentury | Apr 5, 2010
Company News

Devicor Medical Products Inc., J&J deal

...markets the Mammotome breast biopsy system. The acceptance period for the offer ends June 15. Devicor Medical Products Inc....
Items per page:
1 - 3 of 3